Major histocompatibility complex - Wikipedia
Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour immunity | bioRxiv
Cells | Free Full-Text | Avian MHC Evolution in the Era of Genomics: Phase 1.0
Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity | Nature Cancer
Advances in the Evolutionary Understanding of MHC Polymorphism - ScienceDirect
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope | Nature Communications
Major histocompatibility complex - Wikiwand
Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations
PDF) Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity
![Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2018/5118/1/fig-1-full.png "Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance [PeerJ]")
Peptide presentation by HLA-DQ molecules is associated with the development of immune tolerance [PeerJ]
MHC II immunogenicity shapes the neoepitope landscape in human tumors | Nature Genetics
Proto-oncogene PML controls genes devoted to MHC class I antigen presentation | Nature
4. Szeged_ENG_web.indd
Mutant MHC class II epitopes drive therapeutic immune responses to cancer | Nature
Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations | PLOS Biology
Major histocompatibility complex - Wikipedia
Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour immunity | bioRxiv
Advances in the Evolutionary Understanding of MHC Polymorphism: Trends in Genetics
Cells | Free Full-Text | Avian MHC Evolution in the Era of Genomics: Phase 1.0
Mate Manczinger (@matemanc) / Twitter
Mate Manczinger (@matemanc) / Twitter
Molecules | Free Full-Text | Critical Review of Existing MHC I Immunopeptidome Isolation Methods
Máté MANCZINGER | Principal Investigator | PhD | Biological Research Centre, Hungarian Academy of Sciences, Szeged | BRC | Institute of Biochemistry | Research profile
Pathogen diversity drives the evolution of promiscuous peptide binding of human MHC-II alleles | bioRxiv
